Ticker
CRDFCompany Name
CARDIFF ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 220.2M | $ 51.62M | $ 0 | $ 0 | -23.44% |
3/31/2025 | $ 174.96M | $ 53.68M | $ 0 | $ 0 | -30.68% |
12/31/2024 | $ 270.09M | $ 53.78M | $ 0 | $ 0 | -19.91% |
9/30/2024 | $ 209.14M | $ 9.59M | $ 0 | $ 0 | -4.59% |
6/30/2024 | $ 99.15M | $ 2.17M | $ 0 | $ 0 | -2.18% |
3/31/2024 | $ 200.37M | $ 107K | $ 0 | $ 0 | -0.05% |
12/31/2023 | $ 78.86M | $ 0 | $ 0 | $ 0 | 0% |
9/30/2023 | $ 50.93M | $ 0 | $ 0 | $ 0 | 0% |
6/30/2023 | $ 85.33M | $ 75K | $ 0 | $ 0 | -0.09% |
3/31/2023 | $ 87.12M | $ 75K | $ 0 | $ 0 | -0.09% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CARDIFF ONCOLOGY INC is calculated as follows: (-1 * CF - Equity [ $ 41.7M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 305K ]) / Market Cap [ $ 600.52M ]
(=) Shareholder Yield [ -6.99% ]
Minimum
Jun 30, 2021
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |